Frexalimab
Search documents
Royalty Pharma (NasdaqGS:RPRX) FY Conference Transcript
2025-12-03 21:50
Royalty Pharma (NasdaqGS:RPRX) FY Conference December 03, 2025 03:50 PM ET Speaker1Royalty Pharma, Terrance Coyne, CFO, Marshall Urist, EVP of Investments. Gentlemen, welcome. Thank you so much for making time to be with us at this conference. Before we get into Q&A, we'd just love to hear your kind of state of the union of the business and what we could look forward to in the next 12 months.Speaker0Yeah, so thanks, Mike, and Umer and Evercore for having us. Yeah, I think 2025 has been a pretty amazing year ...
Royalty Pharma(RPRX) - 2025 FY - Earnings Call Transcript
2025-12-02 21:17
Royalty Pharma (NasdaqGS:RPRX) FY 2025 Conference December 02, 2025 03:15 PM ET Company ParticipantsTerrance Coyne - CFOMarshall Urist - Head of Research and InvestmentsNone - ModeratorNoneBiopharma analyst and today we have Royalty Pharma, so we have Terry Coyne, CFO; Marshall Urist, EVP, Head of R&I, research and investments. Right. Once that R&D and people got really.Marshall UristKind of like hooked up, yeah.Yeah. Yeah.Okay.Dana like almost fired me. Yeah. So, I guess on the back of a very successful ye ...